Santa Clara, CA, United States of America

Rebecca M Lui

This inventor holds 42 USPTO granted patents and 11 published patent applications, plus 8 CIPO patents and 14 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Chemocentryx, Inc., Amgen Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rebecca M Lui. Retrieved from https://idiyas.com/inventor/rebecca-m-lui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 42 (Patent Applications = 11)

% Patents Active = 100.0

CIPO Patents = 8 (Patent Applications = 15)

EPO Patents = 14 (Patent Applications = 18)

Average Co-Inventor Count = 8.8

ph-index = 6

Forward Citations = 116(Granted Patents)

Location History:

Santa Clara, CA (US) (2014 - 2022)
Mountain View, CA (US) (2021 - 2024)

Company Filing History:

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

PD-L1 Treatments

C5aR Antagonists

CXCR7 Inhibitors

Heteroaryl Compounds

Aryl Sulfonamides

Tetrahydropyrans

Immunomodulators

Oxindole Compounds

Fused Ring Compounds

CCR6 Modulators

Diaryls

Substituted Amides

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12611404 - Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides (2026-04-28),

2. 12497383 - Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases (2025-12-16),

3. 12448373 - Azetidinyl-acetamides as CXCR7 inhibitors (2025-10-21),

4. 12371433 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases (2025-07-29),

5. 12139475 - 2-oxindole compounds (2024-11-12),

6. 12054484 - Substituted tetrahydropyrans as CCR2 modulators (2024-08-06),

7. 12018016 - Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors (2024-06-25),

8. 11866429 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases (2024-01-09),

9. 11845729 - Processes and intermediates in the preparation of C5aR antagonists (2023-12-19),

10. 11834452 - CXCR7 antagonists (2023-12-05),

11. 11807609 - Deuterated compounds as immunomodulators (2023-11-07),

12. 11773091 - 6-5 fused rings as C5a inhibitors (2023-10-03),

13. 11713307 - Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases (2023-08-01),

14. 11608336 - Prodrugs of fused-bicyclic C5aR antagonists (2023-03-21),

15. 11603356 - Amorphous form of a complement component C5a receptor (2023-03-14),

Title: The Innovative Journey of Rebecca M Lui

Introduction: Rebecca M Lui, a pioneering inventor based in Santa Clara, CA, has made significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Rebecca M Lui's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time and a patented software algorithm that enhances cybersecurity measures for businesses.

Career Highlights: With a career spanning over two decades, Rebecca M Lui has established herself as a leading figure in the tech industry. Her work has been recognized with numerous awards, including the prestigious Innovation Award for Technology Advancement.

Collaborations: Throughout her career, Rebecca M Lui has collaborated with top research institutions and universities to further develop her inventions. Her partnerships have led to the creation of cutting-edge technologies that have reshaped various sectors.

Conclusion: Rebecca M Lui's passion for innovation and dedication to pushing the boundaries of technology continue to inspire the next generation of inventors. Her impact on the industry is profound, and her legacy will undoubtedly endure for years to come.

Profile summary based on public USPTO records.